Swimming Motility Mediates the Formation of Neutrophil Extracellular Traps Induced by Flagellated Pseudomonas aeruginosa.

作者: Madison Floyd , Matthew Winn , Christian Cullen , Payel Sil , Benoit Chassaing

DOI: 10.1371/JOURNAL.PPAT.1005987

关键词:

摘要: Pseudomonas aeruginosa is an opportunistic pathogen causing severe infections often characterized by robust neutrophilic infiltration. Neutrophils provide the first line of defense against P. aeruginosa. Aside from their conferred phagocytic activity, neutrophils also release neutrophil extracellular traps (NETs) to immobilize bacteria. Although NET formation important antimicrobial process, details its mechanism are largely unknown. The identity main components responsible for triggering unclear. In this study, our focus was identify bacterial factors mediating and gain insight into underlying mechanism. We found that in exponential growth phase promoted strong human while NET-inducing ability dramatically decreased at later stages growth. identified flagellum as primary component inducing extrusion flagellum-deficient bacteria remained seriously impaired formation. Purified flagellin, monomeric flagellum, does not stimulate neutrophils. aeruginosa-induced independent flagellum-sensing receptors TLR5 NLRC4 both mouse Interestingly, we flagellar motility, binding per se, mediates induced flagellated Immotile, motor-deficient strains producing paralyzed flagella did induce Forced contact between immotile restored ability. Both motAB motCD genetic loci encoding motor genes contribute maximal release; however play a more role. Phagocytosis superoxide production were dependent upon functional flagellum. Taken together, herein presented time organelle planktonic release. Furthermore, rather than on host cells, required

参考文章(101)
Linda Vong, Philip M. Sherman, Michael Glogauer, Quantification and Visualization of Neutrophil Extracellular Traps (NETs) from Murine Bone Marrow-Derived Neutrophils Mouse Models of Innate Immunity. ,vol. 1960, pp. 41- 50 ,(2013) , 10.1007/978-1-62703-481-4_5
Fumitaka Hayashi, Kelly D. Smith, Adrian Ozinsky, Thomas R. Hawn, Eugene C. Yi, David R. Goodlett, Jimmy K. Eng, Shizuo Akira, David M. Underhill, Alan Aderem, The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. ,vol. 410, pp. 1099- 1103 ,(2001) , 10.1038/35074106
Fikreta Grabcanovic-Musija, Astrid Obermayer, Walter Stoiber, Wolf-Dietrich Krautgartner, Peter Steinbacher, Nicole Winterberg, Arne Cornelius Bathke, Michaela Klappacher, Michael Studnicka, None, Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation Respiratory Research. ,vol. 16, pp. 59- 59 ,(2015) , 10.1186/S12931-015-0221-7
Pradeep K. Singh, Amy L. Schaefer, Matthew R. Parsek, Thomas O. Moninger, Michael J. Welsh, E. P. Greenberg, Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms Nature. ,vol. 407, pp. 762- 764 ,(2000) , 10.1038/35037627
Walter Stoiber, Astrid Obermayer, Peter Steinbacher, Wolf-Dietrich Krautgartner, The Role of Reactive Oxygen Species (ROS) in the Formation of Extracellular Traps (ETs) in Humans Biomolecules. ,vol. 5, pp. 702- 723 ,(2015) , 10.3390/BIOM5020702
R. Moore, F. Sahid, C.N. Menezes, I.A. Bahemia, A. Muganza, Microbiology and antibiotic resistance in severe burns patients: A 5 year review in an adult burns unit Burns. ,vol. 41, pp. 1536- 1542 ,(2015) , 10.1016/J.BURNS.2015.05.007
Katherine M. Langan, Tom Kotsimbos, Anton Y. Peleg, Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis Current Opinion in Infectious Diseases. ,vol. 28, pp. 547- 556 ,(2015) , 10.1097/QCO.0000000000000217
Dae-goon Yoo, Matthew Winn, Lan Pang, Samuel M. Moskowitz, Harry L. Malech, Thomas L. Leto, Balázs Rada, Release of Cystic Fibrosis Airway Inflammatory Markers fromPseudomonas aeruginosa–Stimulated Human Neutrophils Involves NADPH Oxidase-Dependent Extracellular DNA Trap Formation The Journal of Immunology. ,vol. 192, pp. 4728- 4738 ,(2014) , 10.4049/JIMMUNOL.1301589